These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 28234254)

  • 21. Regional Amyloid Accumulation and White Matter Integrity in Cognitively Normal Individuals.
    Wang YJ; Hu H; Yang YX; Zuo CT; Tan L; Yu JT;
    J Alzheimers Dis; 2020; 74(4):1261-1270. PubMed ID: 32176644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Independent and Interactive Influences of the APOE Genotype and Beta-Amyloid Burden on Cognitive Function in Mild Cognitive Impairment.
    Seo EH; Kim SH; Park SH; Kang SH; Choo IH;
    J Korean Med Sci; 2016 Feb; 31(2):286-95. PubMed ID: 26839485
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of the APOEɛ4 Allele on the Relationship Between Tau and Amyloid-β in Early- and Late-Onset Alzheimer's Disease.
    Kang JM; Shin JH; Kim WR; Seo S; Seo H; Lee SY; Park KH; Na DL; Okamura N; Seong JK; Noh Y
    J Alzheimers Dis; 2023; 94(3):1233-1246. PubMed ID: 37393505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beta-amyloid associated differential effects of APOE ε4 on brain metabolism in cognitively normal elderly.
    Yi D; Lee DY; Sohn BK; Choe YM; Seo EH; Byun MS; Woo JI
    Am J Geriatr Psychiatry; 2014 Oct; 22(10):961-70. PubMed ID: 24495404
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of apolipoprotein E4-cerebrospinal fluid β-amyloid interaction on hippocampal volume loss over 1 year in mild cognitive impairment.
    Chiang GC; Insel PS; Tosun D; Schuff N; Truran-Sacrey D; Raptentsetsang ST; Thompson PM; Reiman EM; Jack CR; Fox NC; Jagust WJ; Harvey DJ; Beckett LA; Gamst A; Aisen PS; Petersen RC; Weiner MW;
    Alzheimers Dement; 2011 Sep; 7(5):514-20. PubMed ID: 21889115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BDNF Val66Met, Aβ amyloid, and cognitive decline in preclinical Alzheimer's disease.
    Lim YY; Villemagne VL; Laws SM; Ames D; Pietrzak RH; Ellis KA; Harrington KD; Bourgeat P; Salvado O; Darby D; Snyder PJ; Bush AI; Martins RN; Masters CL; Rowe CC; Nathan PJ; Maruff P;
    Neurobiol Aging; 2013 Nov; 34(11):2457-64. PubMed ID: 23769397
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decline in cognitive function over 18 months in healthy older adults with high amyloid-β.
    Ellis KA; Lim YY; Harrington K; Ames D; Bush AI; Darby D; Martins RN; Masters CL; Rowe CC; Savage G; Szoeke C; Villemagne VL; Maruff P;
    J Alzheimers Dis; 2013; 34(4):861-71. PubMed ID: 23302660
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of Butyrylcholinesterase-K Allele and Apolipoprotein E ɛ4 Allele with Cognitive Decline in Dementia with Lewy Bodies and Alzheimer's Disease.
    Vijayaraghavan S; Darreh-Shori T; Rongve A; Berge G; Sando SB; White LR; Auestad BH; Witoelar A; Andreassen OA; Ulstein ID; Aarsland D
    J Alzheimers Dis; 2016; 50(2):567-76. PubMed ID: 26757188
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trajectories of memory decline in preclinical Alzheimer's disease: results from the Australian Imaging, Biomarkers and Lifestyle Flagship Study of ageing.
    Pietrzak RH; Lim YY; Ames D; Harrington K; Restrepo C; Martins RN; Rembach A; Laws SM; Masters CL; Villemagne VL; Rowe CC; Maruff P;
    Neurobiol Aging; 2015 Mar; 36(3):1231-8. PubMed ID: 25585532
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Physical activity and amyloid-β plasma and brain levels: results from the Australian Imaging, Biomarkers and Lifestyle Study of Ageing.
    Brown BM; Peiffer JJ; Taddei K; Lui JK; Laws SM; Gupta VB; Taddei T; Ward VK; Rodrigues MA; Burnham S; Rainey-Smith SR; Villemagne VL; Bush A; Ellis KA; Masters CL; Ames D; Macaulay SL; Szoeke C; Rowe CC; Martins RN
    Mol Psychiatry; 2013 Aug; 18(8):875-81. PubMed ID: 22889922
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin Resistance is Associated with Higher Cerebrospinal Fluid Tau Levels in Asymptomatic APOEɛ4 Carriers.
    Starks EJ; Patrick O'Grady J; Hoscheidt SM; Racine AM; Carlsson CM; Zetterberg H; Blennow K; Okonkwo OC; Puglielli L; Asthana S; Dowling NM; Gleason CE; Anderson RM; Davenport-Sis NJ; DeRungs LM; Sager MA; Johnson SC; Bendlin BB
    J Alzheimers Dis; 2015; 46(2):525-33. PubMed ID: 25812851
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of Alzheimer's Disease-Associated Risk Loci on Amyloid-β Accumulation in the Brain of Idiopathic Normal Pressure Hydrocephalus Patients.
    Laiterä T; Paananen J; Helisalmi S; Sarajärvi T; Huovinen J; Laitinen M; Rauramaa T; Alafuzoff I; Remes AM; Soininen H; Haapasalo A; Jääskeläinen JE; Leinonen V; Hiltunen M
    J Alzheimers Dis; 2017; 55(3):995-1003. PubMed ID: 27802227
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease.
    Mattsson N; Insel PS; Donohue M; Landau S; Jagust WJ; Shaw LM; Trojanowski JQ; Zetterberg H; Blennow K; Weiner MW;
    Brain; 2015 Mar; 138(Pt 3):772-83. PubMed ID: 25541191
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Higher prevalence of cerebral white matter hyperintensities in homozygous APOE-ɛ4 allele carriers aged 45-75: Results from the ALFA study.
    Rojas S; Brugulat-Serrat A; Bargalló N; Minguillón C; Tucholka A; Falcon C; Carvalho A; Morán S; Esteller M; Gramunt N; Fauria K; Camí J; Molinuevo JL; Gispert JD
    J Cereb Blood Flow Metab; 2018 Feb; 38(2):250-261. PubMed ID: 28492093
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anterior Cingulate Structure and Perfusion is Associated with Cerebrospinal Fluid Tau among Cognitively Normal Older Adult APOEɛ4 Carriers.
    Hays CC; Zlatar ZZ; Meloy MJ; Osuna J; Liu TT; Galasko DR; Wierenga CE
    J Alzheimers Dis; 2020; 73(1):87-101. PubMed ID: 31743999
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential Effect of APOE ɛ4 Status and Elevated Pulse Pressure on Functional Decline in Cognitively Normal Older Adults.
    Werhane ML; Thomas KR; Edmonds EC; Bangen KJ; Tran M; Clark AL; Nation DA; Gilbert PE; Bondi MW; Delano-Wood L;
    J Alzheimers Dis; 2018; 62(4):1567-1578. PubMed ID: 29562507
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comorbidity of Cerebrovascular and Alzheimer's Disease in Aging.
    Xia Y; Yassi N; Raniga P; Bourgeat P; Desmond P; Doecke J; Ames D; Laws SM; Fowler C; Rainey-Smith SR; Martins R; Maruff P; Villemagne VL; Masters CL; Rowe CC; Fripp J; Salvado O;
    J Alzheimers Dis; 2020; 78(1):321-334. PubMed ID: 32986666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decreased Inter-Hemispheric Functional Connectivity in Cognitively Intact Elderly APOE ɛ4 Carriers: A Preliminary Study.
    Luo X; Qiu T; Xu X; Huang P; Gu Q; Shen Z; Yu X; Jia Y; Guan X; Song R; Zhang M;
    J Alzheimers Dis; 2016; 50(4):1137-48. PubMed ID: 26836191
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trajectories of amyloid beta accumulation - Unveiling the relationship with APOE genotype and cognitive decline.
    Wybitul M; Buchmann A; Langer N; Hock C; Treyer V; Gietl A;
    Neurobiol Aging; 2024 Jul; 139():44-53. PubMed ID: 38593527
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Arterial spin labeling imaging reveals widespread and Aβ-independent reductions in cerebral blood flow in elderly apolipoprotein epsilon-4 carriers.
    Michels L; Warnock G; Buck A; Macauda G; Leh SE; Kaelin AM; Riese F; Meyer R; O'Gorman R; Hock C; Kollias S; Gietl AF
    J Cereb Blood Flow Metab; 2016 Mar; 36(3):581-95. PubMed ID: 26661143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.